Medical Disclaimer

Last updated: 5/26

Celmedica.com (“Celmedica,” “we,” “us,” or “our”) is an independent editorial directory and information resource for consumers researching regenerative medicine, stem cell therapy, platelet-rich plasma (PRP), NAD+ intravenous therapy, peptide therapy, exosomes, and related longevity and wellness topics. The information published on Celmedica is intended for general educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Please read this disclaimer carefully before using any information found on this site or relying on any clinic listing, treatment description, product mention, or comparison published here.

1. Informational Purposes Only

All content published on Celmedica — including articles, state legal guides, clinic directory listings, product reviews, comparisons, FAQs, infographics, downloadable resources, and email communications — is provided for general informational and educational purposes only. Nothing on this site constitutes medical advice, legal advice, financial advice, or any other form of professional advice.

You should not act, or refrain from acting, based on anything you read on Celmedica without first consulting a licensed healthcare provider who is qualified to evaluate your individual circumstances.

2. No Doctor–Patient Relationship

Reading content on Celmedica, contacting us through any form, signing up for our email list, or interacting with any feature of this site does not create a physician–patient, advisor–client, or any other professional relationship between you and Celmedica, its authors, editors, contributors, advisors, or owners.

Clinics and providers listed in our directory are independent third parties. A listing on Celmedica does not constitute endorsement, recommendation, or warranty of the clinic’s qualifications, practices, outcomes, regulatory status, or fitness for any particular individual. We do not verify, and cannot warrant, the accuracy of any individual clinic’s claims, the credentials of any individual provider, or the safety or efficacy of any therapy offered by a third-party clinic.

If you choose to contact a clinic listed in our directory, any subsequent doctor–patient relationship is between you and that clinic only.

3. Regenerative Medicine: Specific Risks and Limitations

Regenerative medicine — including stem cell therapy, PRP, exosomes, peptide therapy, NAD+ IV, and related interventions — is a developing area of medicine. Many of the therapies discussed on Celmedica are:

• Not approved by the U.S. Food and Drug Administration (FDA) for some, most, or all of the conditions for which they are commonly marketed.
• Subject to evolving federal and state regulation, including ongoing FDA enforcement against unapproved cell and tissue products.
• Associated with known and theoretical risks, including infection, immune reaction, ectopic tissue formation, embolism, treatment failure, and financial harm.
• Variable in quality, dosage, and protocol across providers, even within the same nominal category of therapy.

Outcomes vary by patient, provider, technique, and condition. Anecdotal reports, case series, and individual testimonials do not establish safety or efficacy. You should not assume that any therapy described, mentioned, or reviewed on Celmedica is safe or effective for you, or that it has been adequately tested for the use you are considering.

Before pursuing any regenerative medicine treatment, you should consult one or more licensed healthcare providers, ideally including (a) the physician who would administer the treatment and (b) an independent physician familiar with your medical history. Ask about FDA approval status, alternatives, risks, expected outcomes, evidence base, and full out-of-pocket costs including possible complications.

4. FDA Statements and Investigational Therapies

Celmedica’s content frequently references therapies, products, and procedures that have not been evaluated or approved by the FDA for the specific uses discussed. Where this is the case, we make reasonable efforts to disclose it.

No statement on Celmedica should be interpreted as an FDA-approved claim, an indication of FDA endorsement, or a representation that any therapy or product has been demonstrated to be safe or effective for any particular condition.

References to clinical research, preliminary studies, mechanistic evidence, or user-reported outcomes are provided for informational purposes and do not constitute evidence of clinical effectiveness sufficient to support a medical decision in your individual case.

Federal Right to Try laws and state right-to-try laws have narrow eligibility requirements and apply only to specific investigational products accessed through specific channels. Statements about right-to-try frameworks on Celmedica are general and do not authorize, recommend, or facilitate any specific patient’s access to any specific investigational therapy.

5. Dietary Supplements and Wellness Products

Some Celmedica content discusses dietary supplements, nutraceuticals, peptides, herbal products, and related wellness products. The following statements apply to all such discussion:

These statements have not been evaluated by the Food and Drug Administration. Any product mentioned, reviewed, or recommended is not intended to diagnose, treat, cure, or prevent any disease.

Dietary supplements are regulated by the FDA under the Dietary Supplement Health and Education Act (DSHEA) of 1994 as a category distinct from drugs. The FDA does not pre-approve dietary supplements for safety or efficacy. Quality, potency, and identity of dietary supplements can vary by manufacturer and batch.

You should not use any dietary supplement, peptide, or wellness product mentioned on Celmedica without first consulting a qualified healthcare provider — particularly if you are pregnant, nursing, taking prescription medication, managing a chronic condition, or preparing for surgery.

6. Affiliate Relationships

Celmedica participates in affiliate marketing programs. We may earn commissions when readers purchase products or services through links on this site. Our affiliate relationships do not influence the substance of our editorial content, and we disclose affiliate links in compliance with the Federal Trade Commission’s endorsement guidelines.

For the full details of our affiliate relationships and how we manage potential conflicts of interest, please see our Affiliate Disclosure.

7. Editorial Standards and Source Quality

Celmedica’s editorial process aims to ground claims in peer-reviewed research, primary regulatory sources (FDA, FTC, state medical boards, state legislatures), and verifiable institutional reporting. Where possible, we link to primary sources rather than secondary commentary.

Despite reasonable efforts, errors, omissions, and out-of-date information can occur. Federal and state regulations, FDA enforcement priorities, clinical research findings, and clinic operating status all change over time. Material on Celmedica is correct, to the best of our knowledge, on the date stated as “last reviewed” or “last updated” — but you should independently verify any specific claim before relying on it for a medical or legal decision.

If you identify an error in our content, please contact us at [editorial contact email].

8. Author and Medical Review

Celmedica articles are authored by [author name(s)] and, where indicated, medically reviewed by [Medical Advisor name(s) and credentials, if applicable]. The presence of a medical reviewer signals that a licensed clinician has reviewed the article for general consistency with current medical understanding; it does not constitute personalized medical advice or a clinical recommendation for any individual reader.

Articles without a medical reviewer byline are not reviewed by a licensed clinician and should be treated as general editorial content only.

9. Geographic Scope and State Law Variations

Celmedica’s editorial focus is the United States. Regulatory information on this site, including state-specific legal guides, addresses U.S. federal regulation and U.S. state-level regulation only. Laws, regulations, and clinical practices in other countries are different and are not covered here.

State law on regenerative medicine, IV therapy, medical practice, telemedicine, and dietary supplement marketing varies materially across the United States and changes over time. Our state legal guides describe the general landscape as of the date stated; they do not replace direct verification with the relevant state medical board, state attorney general, or a licensed attorney admitted to practice in your state.

Outside the United States, please consult local healthcare providers and local regulators for guidance applicable to your jurisdiction.

10. Emergency Situations

Celmedica is not designed for and must not be used as a source of urgent or emergency medical information.

If you are experiencing a medical emergency, including symptoms of stroke, heart attack, severe allergic reaction, suicidal thoughts, or any condition that may be life-threatening, call 911 (in the United States) or your local emergency number immediately, or go to the nearest hospital emergency department.

For mental health crisis support in the United States, call or text 988 to reach the Suicide and Crisis Lifeline.

Do not delay seeking emergency care because of anything you have read on this site.

11. Limitation of Liability

To the maximum extent permitted by applicable law:

• Celmedica, its owners, employees, authors, editors, contributors, advisors, and affiliates make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of any information, products, services, clinic listings, or related material on the site for any purpose.
• Any reliance you place on information found on Celmedica is strictly at your own risk.
• In no event will Celmedica or its principals be liable for any loss or damage — including without limitation indirect or consequential loss or damage, loss of data, loss of profit, personal injury, or any loss arising from medical decisions made based on Celmedica content — arising out of, or in connection with, the use of this site.

Nothing in this disclaimer is intended to exclude liability that cannot be excluded under applicable law, including the law of any U.S. state with which you have a relevant connection.

12. Third-Party Links and Third-Party Content

Celmedica contains links to third-party websites, including clinic websites, manufacturer pages, regulatory agencies, academic journals, news outlets, and product retailers. We have no control over, and assume no responsibility for, the content, privacy practices, or operating conduct of any third party. Inclusion of a link does not imply endorsement.

13. Changes to This Disclaimer

We may update this Medical Disclaimer from time to time to reflect changes in the law, regulatory landscape, editorial practices, or operational structure of the site. Any changes will be reflected by an updated “Last updated” date at the top of this page. Material changes will be communicated through a notice on the homepage or in our email communications, where appropriate.

Your continued use of Celmedica after any update constitutes acceptance of the revised disclaimer.

14. Contact

For questions about this disclaimer, corrections to editorial content, or concerns about a specific article, clinic listing, or product mention, please contact:

Celmedica Editorial Email: admin @ celmedica.com

This Medical Disclaimer is provided for transparency and reader safety. It does not constitute legal advice. Celmedica encourages every user to consult their own qualified healthcare provider before making any medical decision and, where appropriate, an attorney admitted to practice in their state on questions of healthcare law.